XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income, net of tax
Accumulated Deficit
Balance at Dec. 31, 2023 $ 89,420 $ 1 $ 400,685 $ 33 $ (311,355)
Balance, Shares at Dec. 31, 2023   1,144,291      
Exercise of common stock options 3   3    
Exercise of common stock options, Shares   18      
Shares issued under ATM, net of issuance costs 4,850   4,850    
Shares issued under ATM, net of issuance costs   20,833      
Exercise of pre-funded warrants 2   2    
Exercise of pre-funded warrants, Shares   25,110      
Exercise of common stock warrants 3,808   3,808    
Exercise of common stock warrants, Shares   28,485      
Issuance of common stock upon RSU vesting, shares   557      
Unrealized loss on available-for-sale securities (8)     (8)  
Stock-based compensation 1,881   1,881    
Net Income (Loss) (22,452)       (22,452)
Balance at Mar. 31, 2024 77,504 $ 1 411,229 25 (333,807)
Balance, Shares at Mar. 31, 2024   1,219,294      
Balance at Dec. 31, 2023 89,420 $ 1 400,685 33 (311,355)
Balance, Shares at Dec. 31, 2023   1,144,291      
Net Income (Loss) (70,583)        
Balance at Jun. 30, 2024 30,973 $ 1 412,858 (4) (381,938)
Balance, Shares at Jun. 30, 2024   1,309,112      
Balance at Mar. 31, 2024 77,504 $ 1 411,229 25 (333,807)
Balance, Shares at Mar. 31, 2024   1,219,294      
Exercise of common stock options, Shares   1      
Exercise of pre-funded warrants 4 $ 0 4    
Exercise of pre-funded warrants, Shares   89,817      
Unrealized loss on available-for-sale securities (29)     (29)  
Stock-based compensation 1,625   1,625    
Net Income (Loss) (48,131)       (48,131)
Balance at Jun. 30, 2024 30,973 $ 1 412,858 $ (4) (381,938)
Balance, Shares at Jun. 30, 2024   1,309,112      
Balance at Dec. 31, 2024 11,594 $ 1 416,383   (404,790)
Balance, Shares at Dec. 31, 2024   1,310,308      
Issuance of common stock upon RSU vesting, shares   7,302      
Stock-based compensation 825   825    
Net Income (Loss) (8,547)       (8,547)
Balance at Mar. 31, 2025 3,872 $ 1 417,208   (413,337)
Balance, Shares at Mar. 31, 2025   1,317,610      
Balance at Dec. 31, 2024 11,594 $ 1 416,383   (404,790)
Balance, Shares at Dec. 31, 2024   1,310,308      
Decrease in common stock for rounding down of fractional shares to reflect the 1-for-50 reverse stock split, shares   (1)      
Net Income (Loss) (15,984)        
Balance at Jun. 30, 2025 1,622 $ 2 422,394   (420,774)
Balance, Shares at Jun. 30, 2025   1,625,376      
Balance at Mar. 31, 2025 3,872 $ 1 417,208   (413,337)
Balance, Shares at Mar. 31, 2025   1,317,610      
Decrease in common stock for rounding down of fractional shares to reflect the 1-for-50 reverse stock split, shares   (48)      
Issuance of common stock upon RSU vesting, shares   7,802      
Issuance of common stock and pre-funded warrants, net of issuance costs 4,273 $ 1 4,272    
Issuance of common stock and pre-funded warrants, net of issuance costs, Shares   273,012      
Issuance of common stock upon exercise of pre-funded warrants, Shares   27,000      
Stock-based compensation 914   914    
Net Income (Loss) (7,437)       (7,437)
Balance at Jun. 30, 2025 $ 1,622 $ 2 $ 422,394   $ (420,774)
Balance, Shares at Jun. 30, 2025   1,625,376